Background:
Adults with neurological or cerebrovascular (NeCVD) disease have an elevated risk of influenza-related complications. Whether HD-IIV provides greater relative benefit over SD-IIV in this population is uncertain.
Objective:
To evaluate the relative vaccine effectiveness (rVE) of high-dose inactivate...
M. Yafasov, N. Johansen, D. Modin et al.· Circulation· 0 citations
A prespecified analysis of the complete two-season DAN-RSV trial cohort will examine the vaccine effectiveness (VE) of RSVpreF versus no vaccine on respiratory and CV events among participants with or without pre-existing ASCVD.
M. Pareek, M. Lassen, M. Yafasov et al.· European Heart Journal· 0 citations
AIMS
To investigate the association between serial high-sensitivity cardiac troponin-T (hs-TnT) concentrations and subsequent heart failure in individuals presenting with suspected acute coronary syndrome (ACS).
METHODS AND RESULTS
Utilizing Danish nationwide registries, we identified individuals without known heart...
Philip Ahle Erichsen, Majid Afzal, Christina Byrne et al.· International Journal of Car...· 1 citation
BACKGROUND
Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...
M. Lassen, S. Christensen, M. Yafasov et al.· NEJM Evidence· 1 citation
Abstract Introduction Sex differences in chronic heart failure are well established, but corresponding differences in acute heart failure (AHF), particularly in multimodal imaging findings and short-term recovery, remain incompletely characterized. Methods In this prospective observational study, 567 adults hospitalize...
A. Khoraizat, F. Davidovski, C. Espersen et al.· ESC Heart Failure· 0 citations
Acute heart failure (AHF) is a major global health challenge, yet the relationship between New York Heart Association (NYHA) classification and objective markers such as echocardiography, lung ultrasound (LUS), and biomarkers remains unclear.
A. Al-Rubai, F. Davidovski, C. Espersen et al.· Echocardiography· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.